Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$9.93 - $15.39 $115,019 - $178,262
-11,583 Closed
0 $0
Q3 2021

Oct 28, 2021

SELL
$10.18 - $26.64 $26,121 - $68,358
-2,566 Reduced 18.14%
11,583 $118,000
Q2 2021

Aug 10, 2021

SELL
$18.57 - $35.68 $61,206 - $117,601
-3,296 Reduced 18.89%
14,149 $377,000
Q1 2021

Jul 21, 2021

BUY
$31.0 - $55.72 $1,023 - $1,838
33 Added 0.19%
17,445 $606,000
Q4 2020

Feb 12, 2021

SELL
$37.09 - $48.97 $531,944 - $702,327
-14,342 Reduced 45.17%
17,412 $646,000
Q3 2020

Oct 30, 2020

SELL
$40.47 - $45.5 $406,966 - $457,548
-10,056 Reduced 24.05%
31,754 $1.31 Million
Q2 2020

Aug 05, 2020

SELL
$32.57 - $42.83 $767,381 - $1.01 Million
-23,561 Reduced 36.04%
41,810 $1.7 Million
Q1 2020

May 11, 2020

SELL
$23.3 - $45.96 $32,853 - $64,803
-1,410 Reduced 2.11%
65,371 $2.27 Million
Q4 2019

Feb 13, 2020

BUY
$34.58 - $48.06 $2.31 Million - $3.21 Million
66,781 New
66,781 $2.86 Million
Q2 2019

Jul 08, 2019

SELL
$35.13 - $55.53 $140,730 - $222,453
-4,006 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$42.83 - $59.91 $171,576 - $239,999
4,006 New
4,006 $218,000
Q4 2018

Feb 05, 2019

SELL
$37.97 - $60.16 $194,406 - $308,019
-5,120 Closed
0 $0
Q3 2018

Nov 02, 2018

BUY
$56.3 - $67.25 $6,643 - $7,935
118 Added 2.36%
5,120 $0
Q2 2018

Aug 20, 2018

SELL
$44.9 - $64.95 $161,370 - $233,430
-3,594 Reduced 41.81%
5,002 $0
Q1 2018

May 21, 2018

BUY
$45.35 - $61.65 $389,828 - $529,943
8,596 New
8,596 $0

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $69.4M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.